FDA Must Block Off-Label Diabetes Drug Promos, Group Says
Consumer advocacy group Public Citizen on Tuesday filed a scathing letter urging the U.S. Food and Drug Administration to fine AstraZeneca PLC, Janssen Pharmaceuticals Inc. and other drugmakers for alleged off-label...To view the full article, register now.
Already a subscriber? Click here to view full article